Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy-a retrospective analysis of a register-based patient cohort.

In the palliative-intention group with cancer in the gastroesophageal junction, the fully adjusted Cox regression model showed a trend of higher HR for treatment with other, more unusual chemotherapy, HR 32.53 (95% CI 3.97–266.89) (Supplementary Table 3 ).

also in 53,322 other papers

The direction of the estimates did not change except for reduced HR for esophageal cancer patients treated with carboplatin-fluorouracil in the palliative-intention group, which was not statistically significant, and gastric cancer patients in the palliative-intention group treated with other, more unusual chemotherapy where the association was only marginally statistically significant.

also in 1,110 other papers